Trump’s tariffs won’t alter the trajectory of our national debt or entitlements. For the economy’s sake, the Supreme Court should end this abuse of
Author: admin
Despite U.S. trade war, EOCD expects global economy will grow 3.2% this year
The world economy has proven surprisingly durable in the face of President Donald Trump’s trade wars, the Organization for Economic Cooperation and Development said
Trump promised a San Francisco crime crackdown. His administration did the opposite.
U.S. President Donald Trump vowed this year to flood San Francisco with federal agents – and even soldiers – to crack down on crime.
Madonna pens scathing post against Trump for ‘unthinkable’ decision to ignore World AIDS Day
Singer Madonna criticized President Donald Trump in a scathing Instagram post on Monday after his administration stopped commemorating World AIDS Day.
Gavin Newsom Ruthlessly Trolls Donald Trump’s MRI Scan With His Own Medical Memo
California Gov. Gavin Newsom has upped his Donald Trump trolling game with a biting parody of the president’s belated MRI report. On Monday, the
Former immigration judge files lawsuit accusing Trump administration of bias in her firing
In her lawsuit, Tania Nemer said she was fired because she is a woman, a dual citizen of Lebanon who is the child of
Michael and Susan Dell donate $6.25B to fund ‘Trump accounts’
Michael Dell and his wife pledged $6.25 billion to support the new “Trump accounts” program giving American children $1,000 at birth plus additional bonuses.
Our December High-Yield 6% Dividend Stocks Have Big Total Return Potential
Altria Group Inc. ( NYSE: MO) is one of the world’s largest producers and marketers of cigarettes and other smokable and oral tobacco-related products
The Stock Market Is Doing Something Last Seen When the Dot-Com Bubble Popped, and It’s Sending a Clear Signal Where to Invest Now
They say history doesn’t repeat itself, but it often rhymes. And if we are indeed in a bubble, there’s one stock market indicator that
2 Top Dividend Stocks to Buy Now and Hold For a Decade
Pfizer is launching seven phase 3 studies for PF-4044 soon and plans to initiate an additional 10 (at least) by the end of 2026.